In patients with lung cancer, however, anti–PD-L1 monotherapy without subsequent steroid administration was associated paradoxically with increased survival compared with patients receiving steroids for irAEs (eFigure 11B in Supplement 1). This evidence concerns the gene CD274 and lung cancer.